Skip to main content

Advertisement

Table 2 Summary of the interventions included in this paper and the methods used to develop the TIDieR reports

From: Getting messier with TIDieR: embracing context and complexity in intervention reporting

Intervention/Study Features TIDieR features
Case Name Clinical problem and intervention Population, setting & service provider Stage of Interventiona/Intervention led by Participants in production or other form of stakeholder input (Voice). Time point employed
(i) Telephone DPP Telephone behavioural and motivational support for 9 months to help patients with IGR (impaired glucose regulation) to reduce their risk of developing diabetes. Patients with IGR in the community.
Health advisors and diabetes nurses (secondary care).
Feasibility in Context.
Service led.
Research team members; Clinical team members (health advisors and diabetes nurses); commissioners (CCG and Trust leads); service leads; synthesis of qualitative research with stakeholders. Iteratively during the project to capture the key elements, in collaboration with participants.
(ii) GP referral DPP A nurse facilitator attended selected GP practices, searched the electronic records for patients at risk of diabetes, made an appointment with patients to discuss their condition, and referred appropriate patients to local diabetes prevention programmes. Patients in primary care.
GP practices.
Nurse Practitioner.
Feasibility in Context.
Service led.
Research team members; Clinical (nurse practitioner); commissioners (CCG and Trust leads); synthesis of qualitative research with stakeholders. Iteratively during the project to capture the key elements, in collaboration with participants.
(iii) Community Referral DPP A community organisation and the local authority health improvement team approached members of the public in community settings, completing diabetes risk scores, offering blood tests to those at risk of diabetes and referring eligible people to local diabetes prevention programmes. Members of the public in community settings (churches, workplaces, markets).
Two community organisations working in health promotion and screening with the public.
Feasibility in Context.
Service led.
Research team members; commissioners (CCG and Trust leads); synthesis of qualitative research with stakeholders. Iteratively during the project to capture the key elements, in collaboration with participants.
(iv) SMART –C Booklet Goal setting and commitment intervention to improve behavioural/weight loss outcomes for people living in low socioeconomic areas who are overweight. Members of the public attending local authority weight loss groups in low socioeconomic areas.
Local authority staff (health improvement) delivering lifestyle interventions in the community.
Intervention development.
Research led.
Research Team, with synthesis of content from multiple sources including a qualitative study with staff and service users and patient & public involvement. Iteratively throughout intervention development process
(v) Primary Care Management of AKI Intervention Management of patients who have had an episode of AKI (acute kidney injury) in primary care, using a targeted ‘audit and feedback’ intervention. Audits of hospital discharge summaries and primary care records were used to identify cases of AKI. Educational events about AKI were provided for primary care professionals. Processes of care including action planning, medication reviews, kidney function monitoring and communication with patients were implemented. Patient who has had an episode of AKI and carers.
GP Practice staff (GPs, nurses and practice pharmacists).
Intervention
Development.
Service and research led.
Research team; NIHR CLAHRC GM implementation team.
Intention to be shared with other stakeholders during the project.
At the beginning of the project to inform the study protocol and implementation.
(vi) AKI Sick Day Guidance Management of patients who have had an episode of AKI (acute kidney injury) in primary care, by providing a ‘sick day guidance’ alert card and verbal clarification from a health professional. The guidance informs patients taking potentially nephrotoxic medicines which ones to temporarily stop taking during a short illness (up to 48 h) Patients taking medications known to lead to risk of AKI.
Primary care settings: GP practices, community pharmacy.
Feasibility in context.
Service led.
Research team only. At the end of the project for reporting purposes.
  1. a.The stage of intervention is defined according to a typology of NIHR CLAHRC GM projects developed by Ruth Boaden, Paul Wilson and Ruth McDonald, 2016 [31], which specifies five stages: Exploration (finding out what is going on), Explanation (explaining something new), Development (developing and implementing interventions), Feasibility in Context (implementation of an intervention previously developed somewhere else) and Exploitation (spread of an intervention into routine practice)